The observations of aberrant regulation of GR in neuroblastoma [55], ER in breast cancer [56], and AR in prostate cancer [57] along with the elevated level of MDM2 in advanced stages evinced the strong correlation of MDM2 with steroid regulation. This evidence concerns the gene MDM2 and breast carcinoma.